1. Serum low replacement medium versus serum rich replacement medium for production of Anti-Schistosoma Monoclonal antibody: A comparative study
- Author
-
Hanaa I. Hassanin, Engy M. Alkhateeb, Salwa Hassan, Sherihan M. Elmotawakel, Mohamed Hendawy, Zeinab Demerdash, Faten S. Mahmoud, Shimaa Atta, and Shereen Shawky
- Subjects
Microbiology (medical) ,030219 obstetrics & reproductive medicine ,biology ,Epidemiology ,medicine.drug_class ,Chemistry ,Cell ,Public Health, Environmental and Occupational Health ,biology.organism_classification ,Monoclonal antibody ,Molecular biology ,Specific igm ,03 medical and health sciences ,Hybridoma cell ,0302 clinical medicine ,Infectious Diseases ,medicine.anatomical_structure ,Serum free ,medicine ,030212 general & internal medicine ,Volume concentration ,In vitro cell culture ,Schistosoma - Abstract
Objective to assess the production of Anti-Schistosoma Monoclonal Antibodies by growing IgM producing hybridoma cell line in serum low medium and to evaluate their diagnostic potential to replace the old conventional method in animal ascetic fluid. Methods Highly reactive and specific IgM MAb secreting hybridoma cell line to S. mansoni SEA was cultured in three different media; serum rich replacement medium (conventional), serum low replacement medium (SLRM) and serum free replacement medium (SFRM). Results Cell count and viability were better in conventional medium and SLRM than SFRM. The lower detection limit of the assay Mab of SLRM culture was 1.1 ng/ml of S. mansoni SEA. SFRM was excluded because of the low concentration and reactivity. MAb was tested against 34 human samples. Sensitivity and specificity of the assay for each were 92% and specificity 90% for SLRM respectively. The diagnostic efficacy of the assay was 94%. Conclusions the production and diagnostic efficacy of antischistosomal MAbs was comparable on usage of either in vitro cell culture supernate in SLRM or conventional media.
- Published
- 2020
- Full Text
- View/download PDF